Arvind Chhabra

Mutant KRAS-activated circATXN7 fosters tumor immunoescape by sensitizing tumor-specific T cells to activation-induced cell death

Immune checkpoint therapy—current perspectives and future directions

Activation‐induced cell death of human melanoma specific cytotoxic T lymphocytes is mediated by apoptosis‐inducing factor

Regulatory T-cell response and tumor vaccine-induced cytotoxic T lymphocytes in human melanoma